Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Antimicrobial Agents and Chemotherapy
|
October 31, 1998
Fluconazole versus Candida albicans: a complex relationship
J R Graybill, E Montalbo, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 1999
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients
J L Lopez-Ribot, R K McAtee, S Perea, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 10, 2008
Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice
L K Najvar, R Bocanegra, N P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata
E R Oliveira, A W Fothergill, W R Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 1993
Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate
T R Frieden, F J Bia, P W Heald, et al.
The Journal of Infectious Diseases
|
May 1, 1988
A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis
T F Patterson, J E Patterson, B L Masecar, et al.
Oral Microbiology and Immunology
|
September 14, 2001
Salivary anticandidal activity and saliva composition in an HIV-infected cohort
A L Lin, D A Johnson, T F Patterson, et al.
The Journal of Antimicrobial Chemotherapy
|
February 28, 2002
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
M Martínez, J L López-Ribot, W R Kirkpatrick, et al.
Journal of Clinical Microbiology
|
May 9, 1998
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans
W R Kirkpatrick, R K McAtee, S G Revankar, et al.
Journal of Clinical Microbiology
|
February 12, 1998
Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method
S G Revankar, W R Kirkpatrick, R K McAtee, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Antimicrobial Agents and Chemotherapy
|
October 31, 1998
Fluconazole versus Candida albicans: a complex relationship
J R Graybill, E Montalbo, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 1999
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients
J L Lopez-Ribot, R K McAtee, S Perea, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 10, 2008
Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice
L K Najvar, R Bocanegra, N P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata
E R Oliveira, A W Fothergill, W R Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 1993
Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate
T R Frieden, F J Bia, P W Heald, et al.
The Journal of Infectious Diseases
|
May 1, 1988
A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis
T F Patterson, J E Patterson, B L Masecar, et al.
Oral Microbiology and Immunology
|
September 14, 2001
Salivary anticandidal activity and saliva composition in an HIV-infected cohort
A L Lin, D A Johnson, T F Patterson, et al.
The Journal of Antimicrobial Chemotherapy
|
February 28, 2002
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
M Martínez, J L López-Ribot, W R Kirkpatrick, et al.
Journal of Clinical Microbiology
|
May 9, 1998
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans
W R Kirkpatrick, R K McAtee, S G Revankar, et al.
Journal of Clinical Microbiology
|
February 12, 1998
Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method
S G Revankar, W R Kirkpatrick, R K McAtee, et al.
Page
of 9